Royalty Pharma
Price & Volume
Stats
See more52W Range | $23.73-$38 |
Market Cap | $20.9B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $2.3B |
Revenue Growth (YoY) | 7.7% |
Gross Profit (12 Mos) | $2.6B |
Diluted EPS | $2.29 |
News
See moreYahoo Finance • yesterday
Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT
Yahoo Finance • 7 days ago
Royalty Pharma PLC (NASDAQ:RPRX) Exceeds Q2 2025 Earnings Estimates and Raises Full-Year Guidance
Yahoo Finance • 7 days ago
Royalty Pharma Q2 2025 slides: Double-digit growth and raised guidance
Yahoo Finance • 16 days ago
Royalty Pharma stock hits 52-week high at 36.89 USD
About
CEO | Mr. Pablo Gerardo Legorreta |
CFO | Mr. Terrance P. Coyne |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
